Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


20.03.2017

2 Am J Cardiol
9 Am J Emerg Med
1 Am J Med
3 Arterioscler Thromb Vasc Biol
1 Atherosclerosis
1 BMJ
33 Catheter Cardiovasc Interv
1 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Imaging
3 Circ Cardiovasc Interv
3 Circ Cardiovasc Qual Outcomes
1 Circ J
1 Circ Res
6 Circulation
6 Clin Cardiol
1 Dtsch Med Wochenschr
2 Heart
2 Int J Cardiol
4 J Am Coll Cardiol
2 J Thorac Cardiovasc Surg
2 Lancet
3 Mol Cell Biochem
7 N Engl J Med
4 PLoS One
1 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. FRANSSENS BT, Nathoe HM, Visseren FL, van der Graaf Y, et al
    Relation of Epicardial Adipose Tissue Radiodensity to Coronary Artery Calcium on Cardiac Computed Tomography in Patients at High Risk for Cardiovascular Disease.
    Am J Cardiol. 2017 Feb 11. pii: S0002-9149(17)30130.
    PubMed     Text format     Abstract available

  2. BITTENCOURT MS, Santos RD, Staniak H, Sharovsky R, et al
    Relation of Fasting Triglyceride-Rich Lipoprotein Cholesterol to Coronary Artery Calcium Score (from the ELSA-Brasil Study).
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30132.
    PubMed     Text format     Abstract available


    Am J Emerg Med

  3. CLARET PG, Stiell IG, Yan JW, Clement CM, et al
    Characteristics and outcomes for acute heart failure in elderly patients presenting to the ED.
    Am J Emerg Med. 2016;34:2159-2166.
    PubMed     Text format     Abstract available

  4. MARSCHKE CR, Olaf MF, Makowski DJ
    ST elevation in massive pulmonary embolism: thrombolysis vs percutaneous catheter intervention.
    Am J Emerg Med. 2016;34:2466.
    PubMed     Text format    

  5. KOBAYASHI A, Misumida N, Aoi S, Steinberg E, et al
    STEMI notification by EMS predicts shorter door-to-balloon time and smaller infarct size.
    Am J Emerg Med. 2016;34:1610-3.
    PubMed     Text format     Abstract available

  6. POURAFKARI L, Tajlil A, Ghaffari S, Chavoshi M, et al
    Electrocardiography changes in acute aortic dissection-association with troponin leak, coronary anatomy, and prognosis.
    Am J Emerg Med. 2016;34:1431-6.
    PubMed     Text format     Abstract available

  7. ZEMRAK WR, Kelley E, Kovacic NL, Mooney DM, et al
    Thrombotic complications following the administration of high-dose prothrombin complex concentrate for acute warfarin reversal.
    Am J Emerg Med. 2016;34:1736.
    PubMed     Text format    

  8. MAHESHWARI A, Thenappan T, Das G
    Adding fuel to the fire: Coronary artery dissection complicating blunt chest trauma.
    Am J Emerg Med. 2017 Mar 7. pii: S0735-6757(17)30173.
    PubMed     Text format     Abstract available

  9. CHEN CC, Chiu IM, Cheng FJ, Wu KH, et al
    The impact of prolonged waiting time for coronary care unit admission on patients with non ST-elevation acute coronary syndrome.
    Am J Emerg Med. 2017 Feb 28. pii: S0735-6757(17)30163.
    PubMed     Text format     Abstract available

  10. PARE JR, Liu R, Moore CL, Safdar B, et al
    Corrected flow time: a noninvasive ultrasound measure to detect preload reduction by nitroglycerin.
    Am J Emerg Med. 2016;34:1859-62.
    PubMed     Text format     Abstract available

  11. GULEN B, Eken C, Kucukdagli OT, Serinken M, et al
    Adropin levels and target organ damage secondary to high blood pressure in the ED.
    Am J Emerg Med. 2016;34:2061-2064.
    PubMed     Text format     Abstract available


    Am J Med

  12. HOSOYA H, Levine JJ, Henry DH, Goldberg S, et al
    Double the Trouble: Acute Coronary Syndrome and Ischemic Stroke in Polycythemia Vera.
    Am J Med. 2017 Mar 13. pii: S0002-9343(17)30223.
    PubMed     Text format    


    Arterioscler Thromb Vasc Biol

  13. ARNOLD AP, Cassis LA, Eghbali M, Reue K, et al
    Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.
    Arterioscler Thromb Vasc Biol. 2017 Mar 9. pii: ATVBAHA.116.307301.
    PubMed     Text format     Abstract available

  14. GOETTSCH C, Iwata H, Hutcheson JD, O'Donnell CJ, et al
    Serum Sortilin Associates With Aortic Calcification and Cardiovascular Risk in Men.
    Arterioscler Thromb Vasc Biol. 2017 Mar 9. pii: ATVBAHA.116.308932.
    PubMed     Text format     Abstract available

  15. MORRIS GE, Braund PS, Moore JS, Samani NJ, et al
    Coronary Artery Disease-Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes.
    Arterioscler Thromb Vasc Biol. 2017 Mar 9. pii: ATVBAHA.116.308734.
    PubMed     Text format     Abstract available


    Atherosclerosis

  16. MATSUNAGA M, Yatsuya H, Iso H, Yamashita K, et al
    Similarities and differences between coronary heart disease and stroke in the associations with cardiovascular risk factors: The Japan Collaborative Cohort Study.
    Atherosclerosis. 2017 Mar 6. pii: S0021-9150(17)30093.
    PubMed     Text format     Abstract available


    BMJ

  17. KERMODE-SCOTT B
    Failure of fertility therapy is associated with increased risk of cardiovascular events.
    BMJ. 2017;356:j1293.
    PubMed     Text format    


    Catheter Cardiovasc Interv

  18. HABARA M, Tsuchikane E, Muramatsu T, Kashima Y, et al
    Comparison of percutaneous coronary intervention for chronic total occlusion outcome according to operator experience from the Japanese retrograde summit registry.
    Catheter Cardiovasc Interv. 2015 Dec 31. doi: 10.1002/ccd.26354.
    PubMed     Text format     Abstract available

  19. GOEL SS, Dilip Gajulapalli R, Athappan G, Philip F, et al
    Management of drug eluting stent in-stent restenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2016;87:1080-91.
    PubMed     Text format     Abstract available

  20. NASCIMBENE A, Loyalka P, Gregoric ID, Kar B, et al
    Percutaneous coronary intervention with the TandemHeart percutaneous left ventricular assist device support: Six years of experience and outcomes.
    Catheter Cardiovasc Interv. 2015 Nov 21. doi: 10.1002/ccd.26147.
    PubMed     Text format     Abstract available

  21. YOSHIMACHI F, Torii S, Naito T
    A novel percutaneous coronary intervention technique for chronic total occlusion: Contralateral angiography with a single guiding catheter.
    Catheter Cardiovasc Interv. 2015 Nov 3. doi: 10.1002/ccd.26268.
    PubMed     Text format     Abstract available

  22. LEVINE GN, Bates ER, Blankenship JC, Bailey SR, et al
    2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline f
    Catheter Cardiovasc Interv. 2016;87:1001-19.
    PubMed     Text format    

  23. KOLTE D, Dawn Abbott J
    Saphenous vein graft lesions: Are second-generation drug-eluting stents better?
    Catheter Cardiovasc Interv. 2016;87:41-2.
    PubMed     Text format     Abstract available

  24. CARLINO M, Ruparelia N, Thomas G, Brooks M, et al
    Modified contrast microinjection technique to facilitate chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2016;87:1036-41.
    PubMed     Text format     Abstract available

  25. LADWINIEC A, Cunnington MS, Rossington J, Thackray S, et al
    Microvascular dysfunction in the immediate aftermath of chronic total coronary occlusion recanalization.
    Catheter Cardiovasc Interv. 2016;87:1071-9.
    PubMed     Text format     Abstract available

  26. KLEIN LW, Blankenship JC, Kolansky DM, Dean LS, et al
    SCAI position statement concerning coverage policies for percutaneous coronary interventions based on the appropriate use criteria.
    Catheter Cardiovasc Interv. 2016 Mar 10. doi: 10.1002/ccd.26499.
    PubMed     Text format    

  27. BLANKENSHIP JC
    Passion: A day in the life of an interventionalist.
    Catheter Cardiovasc Interv. 2016;87:999-1000.
    PubMed     Text format    

  28. BANG VV, Levy MS
    In multivessel coronary artery disease, a "state-of-the-art" randomized clinical trial of revascularization is needed.
    Catheter Cardiovasc Interv. 2016;87:13-4.
    PubMed     Text format     Abstract available

  29. PATEL PM, Kern MJ
    PCI in failing saphenous vein grafts: DES trumps BMS for the older patient.
    Catheter Cardiovasc Interv. 2016;87:50-1.
    PubMed     Text format     Abstract available

  30. HILLEGASS WB
    Insulin-treated diabetes mellitus: An important, actionable risk marker after coronary stenting.
    Catheter Cardiovasc Interv. 2016;87:63-4.
    PubMed     Text format     Abstract available

  31. PINTON FA, Lemos PA
    Inflation time in stent deployment: How long is enough?
    Catheter Cardiovasc Interv. 2016;87:73-4.
    PubMed     Text format     Abstract available

  32. SOLA M, Venkatesh K, Caughey M, Rayson R, et al
    Ratio of systolic blood pressure to left ventricular end-diastolic pressure at the time of primary percutaneous coronary intervention predicts in-hospital mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2017 Mar 17. doi: 10.1002/ccd.26963.
    PubMed     Text format     Abstract available

  33. WOLFF R, Fefer P, Knudtson ML, Cheema AN, et al
    Gender differences in the prevalence and treatment of coronary chronic total occlusions.
    Catheter Cardiovasc Interv. 2016;87:1063-70.
    PubMed     Text format     Abstract available

  34. HARI P, Kirtane AJ, Bangalore S
    Retrograde approach to an ostial left anterior descending chronic total occlusion through a left internal mammary artery graft.
    Catheter Cardiovasc Interv. 2016;87:E224-8.
    PubMed     Text format     Abstract available

  35. MIYASAKA M, Tada N, Kato S, Kami M, et al
    Sheathless guide catheter in transradial percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2016;87:1111-7.
    PubMed     Text format     Abstract available

  36. LEE MH, Park JJ, Yoon CH, Cha MJ, et al
    Impact of smoking status on clinical outcomes after successful chronic total occlusion intervention: Korean national registry of CTO intervention.
    Catheter Cardiovasc Interv. 2016;87:1050-62.
    PubMed     Text format     Abstract available

  37. ORVIN K, Carrie D, Richardt G, Desmet W, et al
    Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Catheter Cardiovasc Interv. 2016;87:1092-100.
    PubMed     Text format     Abstract available

  38. ZIMARINO M, Ricci F, Romanello M, Di Nicola M, et al
    Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies.
    Catheter Cardiovasc Interv. 2016;87:3-12.
    PubMed     Text format     Abstract available

  39. KATOH H, Nozue T, Michishita I
    A case of giant saphenous vein graft aneurysm successfully treated with catheter intervention.
    Catheter Cardiovasc Interv. 2016;87:83-9.
    PubMed     Text format     Abstract available

  40. BURZOTTA F, Summaria F, Latib A, De Vita M, et al
    Prospective multicentre clinical performance evaluation of second and third generation zotarolimus-eluting stents to treat patients with bifurcated coronary lesions.
    Catheter Cardiovasc Interv. 2016;87:15-22.
    PubMed     Text format     Abstract available

  41. BARTORELLI AL, Egidy Assenza G, Abizaid A, Banning A, et al
    One-year clinical outcomes after sirolimus-eluting coronary stent implantation in diabetics enrolled in the worldwide e-SELECT registry.
    Catheter Cardiovasc Interv. 2016;87:52-62.
    PubMed     Text format     Abstract available

  42. PANAICH SS, Badheka AO, Arora S, Patel NJ, et al
    Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient sample.
    Catheter Cardiovasc Interv. 2016;87:23-33.
    PubMed     Text format     Abstract available

  43. POKALA NR, Menon RV, Patel SM, Christopoulos G, et al
    Long-term outcomes with first- vs. second-generation drug-eluting stents in saphenous vein graft lesions.
    Catheter Cardiovasc Interv. 2016;87:34-40.
    PubMed     Text format     Abstract available

  44. CARRABBA N, Parodi G, Maehara A, Pradella S, et al
    Rheolityc thrombectomy in acute myocardial infarction: Effect on microvascular obstruction, infarct size, and left ventricular remodeling.
    Catheter Cardiovasc Interv. 2016;87:E1-8.
    PubMed     Text format     Abstract available

  45. MATSUO Y, Kubo T, Aoki H, Satogami K, et al
    Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis.
    Catheter Cardiovasc Interv. 2016;87:E9-E14.
    PubMed     Text format     Abstract available

  46. BRENNAN JM, Sketch MH Jr, Dai D, Trilesskaya M, et al
    Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry((R)) CathPCI Registry((R)) (2005-2009).
    Catheter Cardiovasc Interv. 2016;87:43-9.
    PubMed     Text format     Abstract available

  47. VALLURUPALLI S, Bahia A, Ruiz-Rodriguez E, Ahmed Z, et al
    Optimization of stent implantation using a high pressure inflation protocol.
    Catheter Cardiovasc Interv. 2016;87:65-72.
    PubMed     Text format     Abstract available

  48. MUNOZ-MENDOZA J, Ghatak A, Pinto Miranda V, Bahadu S, et al
    Time-course of vascular dysfunction of brachial artery after transradial access for coronary angiography.
    Catheter Cardiovasc Interv. 2016;87:101-6.
    PubMed     Text format     Abstract available

  49. URETSKY BF, Mathew J, Ahmed Z, Hakeem A, et al
    Percutaneous management of patients with acute coronary syndromes from unprotected left main disease: A comprehensive review and presentation of a treatment algorithm.
    Catheter Cardiovasc Interv. 2016;87:90-100.
    PubMed     Text format     Abstract available

  50. LU H, Ge L, Ge J
    Coronary aneurysm and stent fracture following stenting of a myocardial bridge.
    Catheter Cardiovasc Interv. 2016;87:E15-8.
    PubMed     Text format     Abstract available


    Circ Arrhythm Electrophysiol

  51. KUCK KH, Tilz RR, Deneke T, Hoffmann BA, et al
    Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substr
    Circ Arrhythm Electrophysiol. 2017;10.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Imaging

  52. RAGGI P, Alexopoulos N
    Coronary Artery Plaque Burden Nomograms: Are They Ready for Use?
    Circ Cardiovasc Imaging. 2017;10.
    PubMed     Text format    


    Circ Cardiovasc Interv

  53. GUPTA R, Kirtane AJ, Ozan MO, Witzenbichler B, et al
    Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  54. HAVAKUK O, Goland S, Mehra A, Elkayam U, et al
    Pregnancy and the Risk of Spontaneous Coronary Artery Dissection: An Analysis of 120 Contemporary Cases.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format     Abstract available

  55. SAW J
    Pregnancy-Associated Spontaneous Coronary Artery Dissection Represents an Exceptionally High-Risk Spontaneous Coronary Artery Dissection Cohort.
    Circ Cardiovasc Interv. 2017;10.
    PubMed     Text format    


    Circ Cardiovasc Qual Outcomes

  56. BRADLEY EH, Brewster AL, Fosburgh H, Cherlin EJ, et al
    Development and Psychometric Properties of a Scale to Measure Hospital Organizational Culture for Cardiovascular Care.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available

  57. GHASEMZEDAH N, Hayek SS, Ko YA, Eapen DJ, et al
    Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available

  58. SAUSER ZACHRISON K, Levine DA, Fonarow GC, Bhatt DL, et al
    Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    PubMed     Text format     Abstract available


    Circ J

  59. NAKAMURA R, Nishizaki M, Lee K, Shimizu M, et al
    Life-Threatening Ventricular Arrhythmia and Brugada-Type ST-Segment Elevation Associated With Acute Ischemia of the Right Ventricular Outflow Tract.
    Circ J. 2017;81:322-329.
    PubMed     Text format     Abstract available


    Circ Res

  60. LUO L, Tang J, Nishi K, Yan C, et al
    Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice.
    Circ Res. 2017 Mar 15. pii: CIRCRESAHA.116.310374.
    PubMed     Text format     Abstract available


    Circulation

  61. TANG WH, Hazen SL
    The Gut Microbiome and Its Role in Cardiovascular Diseases.
    Circulation. 2017;135:1008-1010.
    PubMed     Text format    

  62. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available

  63. BOEDDINGHAUS J, Nestelberger T, Twerenbold R, Wildi K, et al
    Direct Comparison of Four Very Early Rule-Out Strategies for Acute Myocardial Infarction Using High-Sensitivity Cardiac Troponin I.
    Circulation. 2017 Mar 10. pii: CIRCULATIONAHA.116.025661.
    PubMed     Text format     Abstract available

  64. BAIREY MERZ CN, Pepine CJ, Walsh MN, Fleg JL, et al
    Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.
    Circulation. 2017;135:1075-1092.
    PubMed     Text format     Abstract available

  65. KHERA AV, Kathiresan S
    Is Coronary Atherosclerosis One Disease or Many? Setting Realistic Expectations for Precision Medicine.
    Circulation. 2017;135:1005-1007.
    PubMed     Text format    

  66. WANG DD, Toledo E, Hruby A, Rosner BA, et al
    Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial.
    Circulation. 2017 Mar 9. pii: CIRCULATIONAHA.116.024261.
    PubMed     Text format     Abstract available


    Clin Cardiol

  67. FRITH E, Loprinzi PD
    The protective effects of a novel fitness-fatness index on all-cause mortality among adults with cardiovascular disease.
    Clin Cardiol. 2017 Mar 10. doi: 10.1002/clc.22679.
    PubMed     Text format     Abstract available

  68. SHAFIQ A, Gosch K, Amin AP, Ting HH, et al
    Predictors and variability of drug-eluting vs bare-metal stent selection in contemporary percutaneous coronary intervention: Insights from the PRISM study.
    Clin Cardiol. 2017 Mar 16. doi: 10.1002/clc.22693.
    PubMed     Text format     Abstract available

  69. KALLA A, Figueredo VM
    Alcohol and cardiovascular disease in the geriatric population.
    Clin Cardiol. 2017 Mar 10. doi: 10.1002/clc.22681.
    PubMed     Text format     Abstract available

  70. BALAKRISHNAN R, Nguyen B, Raad R, Donnino R, et al
    Coronary artery calcification is common on nongated chest computed tomography imaging.
    Clin Cardiol. 2017 Mar 16. doi: 10.1002/clc.22685.
    PubMed     Text format     Abstract available

  71. BHATT DL, Steg PG, Brinton EA, Jacobson TA, et al
    Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.
    Clin Cardiol. 2017 Mar 15. doi: 10.1002/clc.22692.
    PubMed     Text format     Abstract available

  72. LAMPROU V, Varvarousis D, Polytarchou K, Varvarousi G, et al
    The role of thyroid hormones in acute coronary syndromes: Prognostic value of alterations in thyroid hormones.
    Clin Cardiol. 2017 Mar 10. doi: 10.1002/clc.22689.
    PubMed     Text format     Abstract available


    Dtsch Med Wochenschr

  73. MARZ W, Delgado G, Kleber M
    [Gene mutation protects by reducing lipids].
    Dtsch Med Wochenschr. 2016;141:1059.
    PubMed     Text format    


    Heart

  74. NADIR MA
    Inverse prognostic value of post-percutaneous coronary intervention fractional flow reserve in patients with non-ST segment elevation myocardial infarction.
    Heart. 2017;103:564.
    PubMed     Text format    

  75. ANDERSSON DP, Trolle Lagerros Y, Grotta A, Bellocco R, et al
    Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction.
    Heart. 2017 Mar 9. pii: heartjnl-2016-310746. doi: 10.1136/heartjnl-2016-310746.
    PubMed     Text format     Abstract available


    Int J Cardiol

  76. YAVNE Y, Tiosano S, Watad A, Comaneshter D, et al
    Investigating the link between ischemic heart disease and Behcet's disease: A cross-sectional analysis.
    Int J Cardiol. 2017 Mar 1. pii: S0167-5273(16)33200.
    PubMed     Text format     Abstract available

  77. OLIVIER A, Girerd N, Michel JB, Ketelslegers JM, et al
    Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Pos
    Int J Cardiol. 2017 Feb 8. pii: S0167-5273(16)32115.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  78. PATEL MR, Calhoon JH, Dehmer GJ, Grantham JA, et al
    ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association f
    J Am Coll Cardiol. 2017 Mar 9. pii: S0735-1097(17)30385.
    PubMed     Text format    

  79. HANNAN EL, Samadashvili Z, Cozzens K, Gesten F, et al
    Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.
    J Am Coll Cardiol. 2017;69:1234-1242.
    PubMed     Text format     Abstract available

  80. VERBEEK R, Sandhu MS, Hovingh GK, Sjouke B, et al
    Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms.
    J Am Coll Cardiol. 2017;69:1513-1515.
    PubMed     Text format    

  81. SERBAN MC, Colantonio LD, Manthripragada AD, Monda KL, et al
    Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    J Am Coll Cardiol. 2017;69:1386-1395.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  82. CUBERO-GALLEGO H, Lorenzo M, Heredia M, Gomez I, et al
    Diagnosis of perioperative myocardial infarction after heart valve surgery with new cut-off point of high-sensitivity troponin T and new electrocardiogram or echocardiogram changes.
    J Thorac Cardiovasc Surg. 2017 Feb 14. pii: S0022-5223(17)30224.
    PubMed     Text format     Abstract available

  83. MOSQUERA VX, Bouzas-Mosquera A, Gonzalez-Barbeito M, Bautista-Hernandez V, et al
    Indexed left atrial size predicts all-cause and cardiovascular mortality in patients undergoing aortic valve surgery.
    J Thorac Cardiovasc Surg. 2017 Feb 9. pii: S0022-5223(17)30205.
    PubMed     Text format     Abstract available


    Lancet

  84. THE LANCET
    Polypills: an essential medicine for cardiovascular disease.
    Lancet. 2017;389:984.
    PubMed     Text format    

  85. HUFFMAN MD, Xavier D, Perel P
    Uses of polypills for cardiovascular disease and evidence to date.
    Lancet. 2017;389:1055-1065.
    PubMed     Text format     Abstract available


    Mol Cell Biochem

  86. KOLAR D, Gresikova M, Waskova-Arnostova P, Elsnicova B, et al
    Adaptation to chronic continuous hypoxia potentiates Akt/HK2 anti-apoptotic pathway during brief myocardial ischemia/reperfusion insult.
    Mol Cell Biochem. 2017 Mar 13. doi: 10.1007/s11010-017-3001.
    PubMed     Text format     Abstract available

  87. QUAN A, Pan Y, Singh KK, Polemidiotis J, et al
    Cardiovascular inflammation is reduced with methotrexate in diabetes.
    Mol Cell Biochem. 2017 Mar 16. doi: 10.1007/s11010-017-3006.
    PubMed     Text format     Abstract available

  88. SUN J, Wei T, Bai S, Zhao H, et al
    Calcium-sensing receptor-mediated mitogen-activated protein kinase pathway improves the status of transplanted mouse embryonic stem cells in rats with acute myocardial infarction.
    Mol Cell Biochem. 2017 Mar 9. doi: 10.1007/s11010-017-2987.
    PubMed     Text format     Abstract available


    N Engl J Med


  89. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1089.
    PubMed     Text format    

  90. DULLAART RP
    PCSK9 Inhibition to Reduce Cardiovascular Events.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMe1703138.
    PubMed     Text format    

  91. RIDKER PM, Revkin J, Amarenco P, Brunell R, et al
    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1701488.
    PubMed     Text format     Abstract available

  92. RAY KK, Landmesser U, Leiter LA, Kallend D, et al
    Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615758.
    PubMed     Text format     Abstract available

  93. CHRISTIANSEN EH, Makikallio T, Holm NR
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1088-9.
    PubMed     Text format    

  94. BELLEYCOTE EP, Lamy AR, Whitlock RP
    Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.
    N Engl J Med. 2017;376:1087-8.
    PubMed     Text format    

  95. SABATINE MS, Giugliano RP, Keech AC, Honarpour N, et al
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
    N Engl J Med. 2017 Mar 17. doi: 10.1056/NEJMoa1615664.
    PubMed     Text format     Abstract available


    PLoS One

  96. KING W, Lacey A, White J, Farewell D, et al
    Equity in healthcare for coronary heart disease, Wales (UK) 2004-2010: A population-based electronic cohort study.
    PLoS One. 2017;12:e0172618.
    PubMed     Text format     Abstract available

  97. BARDACH AE, Caporale JE, Rubinstein AL, Danaei G, et al
    Impact of level and patterns of alcohol drinking on coronary heart disease and stroke burden in Argentina.
    PLoS One. 2017;12:e0173704.
    PubMed     Text format     Abstract available

  98. ROTH C, Gangl C, Dalos D, Krenn L, et al
    Outcome after Elective Percutaneous Coronary Intervention Depends on Age in Patients with Stable Coronary Artery Disease - An Analysis of Relative Survival in a Multicenter Cohort and an OCT Substudy.
    PLoS One. 2016;11:e0154025.
    PubMed     Text format     Abstract available

  99. NGUYEN A, Mamarbachi M, Turcot V, Lessard S, et al
    Lower Methylation of the ANGPTL2 Gene in Leukocytes from Post-Acute Coronary Syndrome Patients.
    PLoS One. 2016;11:e0153920.
    PubMed     Text format     Abstract available


    Thromb Haemost

  100. THOMAS MR, Angiolillo DJ, Bonaca MP, Ajjan RA, et al
    Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
    Thromb Haemost. 2017 Mar 16. doi: 10.1160/TH16-09-0703.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: